Sari la conținut

Adaptimmune Therapeutics PLC ADR: Diferență între versiuni

Pagină nouă: Pagina dedicata companiei Adaptimmune Therapeutics PLC ADR listata cu simbolul US.ADAP ==Descriere companie== Adaptimmune Therapeutics plc (https://www.adaptimmune.com/) is a clinical-stage biopharmaceutical company that focuses on the development of novel cancer immunotherapy products for people with cancer. The Company’s Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple soli...
(Pagină nouă: Pagina dedicata companiei Adaptimmune Therapeutics PLC ADR listata cu simbolul US.ADAP ==Descriere companie== Adaptimmune Therapeutics plc (https://www.adaptimmune.com/) is a clinical-stage biopharmaceutical company that focuses on the development of novel cancer immunotherapy products for people with cancer. The Company’s Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple soli...)
(Nicio diferență)